Lawmakers are zeroing in on the skyrocketing cost of insulin and putting pressure on manufacturers…
View More Drug pricing fight centers on insulin
Category: Drug
Shortage of Anxiety Drug Leaves Patients Scrambling
A sudden shortage of one of the safest anti-anxiety drugs on the market has spread…
View More Shortage of Anxiety Drug Leaves Patients Scrambling
The Bedaquiline conundrum: Why this TB drug is creating an intense debate
No other drug in recent times created as much buzz as Bedaquiline. Bedaquiline, developed by…
View More The Bedaquiline conundrum: Why this TB drug is creating an intense debate
Govt to form panel on affordable medicines, health products
The government will constitute a standing committee on affordable medicines and health products that would…
View More Govt to form panel on affordable medicines, health products
Drug regulator initiates prosecution proceedings against Snapdeal
The Karnataka government has issued an order permitting authorities concerned to initiate prosecution proceedings in…
View More Drug regulator initiates prosecution proceedings against Snapdeal
Johnson & Johnson raises US prices on around two dozen drugs
Johnson & Johnson raised US prices on around two dozen prescription drugs on Thursday, including…
View More Johnson & Johnson raises US prices on around two dozen drugs
Hetero launches generic breast cancer treatment drug in India
Drug firm Hetero on Friday said it has launched generic Lapatinib tablets, used in the…
View More Hetero launches generic breast cancer treatment drug in India
Use compulsory license and put ceiling to curb prices of patented medicines: Govt panel
In order to cut prices of patented medicines for cancer and rare diseases, a high-level…
View More Use compulsory license and put ceiling to curb prices of patented medicines: Govt panel
Lupin’s specialty drug Solosec gains traction in US on rising prescriptions
Lupin’s speciality drug Solosec, which it hoped would drive future sales in the US, is gaining…
View More Lupin’s specialty drug Solosec gains traction in US on rising prescriptions
Wockhardt gains 3% on USFDA approval for cancer drug
Share price of Wockhardt added more than 3 percent intraday Monday after company received approval…
View More Wockhardt gains 3% on USFDA approval for cancer drug